@newsramp.comSS Innovations (NASDAQ: SSII) reports a 143% surge in robotic procedures and 39% revenue growth in Q2 2026, with 224 systems across 12 countries and FDA review expected by Q1 2027. #SurgicalRobotics #MedTech
• Deploy in <30 days with Zero-PHI wedge
• Slash R&D burn rates by 40-60%
• Retain 100% IP & entity sovereignty
• 3-phase clinical alignment, sandbox stress-testing & US FDA, CE, CDSCO regulatory pipelines.
@mengli512.bsky.socialIs Procept Bio Robotics stock a sustainable long-term investment, or does the recent price decline signal deeper financial trouble?
#PROCEPT #robot #urologicalhealth #surgicalrobotics $PRCT $OUST $TSLA
• 30-day zero-PHI pod deployment
• 40-60% R&D burn rate reduction
• 40-60% faster regulatory submissions
• 100% IP sovereignty & BOT transfer
Accelerate MedTech innovation with surgeon governance.
#SurgicalRobotics #MedTech #Robotics
@yinqihuang.bsky.social@gonelight.bsky.social will be presenting our work "An Adaptive LQG Model of Human Learning in Surgical Robot Teleoperation" at the #IROS2026 SurgTwin Workshop! If you’re attending the workshop, please drop by our poster and say hello! We’d love to chat!
1️⃣ Zero-PHI Ingestion (<30 day deploy)
2️⃣ Clinical Sandbox (Practitioner tested)
3️⃣ FDA/CE/CDSCO Submissions
✅ 40-60% R&D Burn Reduction
✅ 100% IP Sovereignty
✅ ISO 13485 Compliant
@newsramp.comSS Innovations International (NASDAQ: SSII) posted Q2 revenue of $13.9M, up 39.4% year over year, with 224 surgical robotic systems now installed across 12 countries and 12,000+ procedures completed. U.S. and EU regulatory approvals could be next. #SurgicalRobotics #MedTech
